Skip to content

Vagus nerve stimulation treatment for erythematotelangiectatic rosacea: a multi-center, randomized clinical trial

Vagus nerve stimulation treatment for erythematotelangiectatic rosacea: a multi-center, randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118692
Enrollment
Unknown
Registered
2026-02-10
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erythematotelangiectatic rosacea (ETR)

Interventions

Transcutaneous auricular vagus nerve stimulation group:Transcutaneous auricular vagus nerve stimulation

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged between 18 and 60 years (inclusive, with no gender restrictions); 2. Meeting the diagnostic criteria for erythematous telangiectatic rosacea and having a CEA score of 2 or higher; 3. Capable of adhering to the study or follow - up procedures, and collaborating in observing adverse events and therapeutic effects; 4. The patient's voluntary participation in the study and signing of a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Subjects diagnosed with papulopustular, ocular, or rhinophymatous rosacea; 2. Subjects with a CEA score lower than 2; 3. Subjects who have participated in any drug or non - drug clinical research within one month before enrollment; 4. Subjects with bradycardia, severe diseases of important organs (e.g., heart, liver, lungs, and kidneys), hematological disorders, or other diseases that the investigator considers unsuitable for participation in the clinical trial; 5. Subjects with malignant tumors, systemic failure, or low immune function; 6. Subjects with concurrent facial acne, atopic dermatitis, hormone - dependent dermatitis, or other facial skin - related diseases; 7. Subjects with a history of epilepsy, a family history of epilepsy, tic disorders, or other mental and neurological disorders that impede cooperation; 8. Subjects with abscesses, infections, ulcers, edema, or scars on the auricle skin; 9. Subjects who are unwilling or unable to cooperate for any reason.

Design outcomes

Primary

MeasureTime frame
Clinician’s Erythema Assessment score;

Secondary

MeasureTime frame
Patient Health Questionnaire–9;Global Flushing Severity Scale;Generalized Anxiety Disorder–7;Facial Itch Numerical Rating Scale;Patient Self- Assessment score;

Countries

China

Contacts

Public ContactJian Li

The First Affiliated Hospital of Army Medical University

leejian@163.com+86 23 68765784

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026